Home Health Care News June 27, 2024
Joyce Famakinwa

Following its move to decrease VillageMD’s physical footprint, Walgreens Boots Alliance Inc. (Nasdaq: WBA) seems to be doubling down on its decision.

“We don’t have plans to continue to invest in brick and mortar-owned primary care practices,” Mary Langowski, the president of U.S. Healthcare, said during the company’s third-quarter earnings call on Thursday.

VillageMD is a large primary care provider with a home- and community-based focus.

In 2020, Walgreens backed the company with a more than $1 billion investment. Over the course of several investments, Walgreens has poured more than $6 billion into VillageMD.

In March, Walgreens disclosed that it was planning to shut down 160 VillageMD clinics. The company referred to this as the prioritization of “density in their...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech, Provider, Retailer
First Comprehensive Review of SMA Drugs Offers Long-Term Insights, Outcome Gaps
Full FDA Approval of Travere’s Kidney Drug Stiffens Competition With Novartis, Calliditas
Drugmaker might be 1st healthcare company to top $1 trillion valuation
Prescription drug spending grew even after rebates
Remote monitoring and pharmacist helps improve hard-to-control blood pressure, research shows

Share This Article